10.9 C
New York
Wednesday, April 24, 2024
HomeMarkets
Markets

Chembio Diagnostics' Stock Suddenly Got Interesting

By Insider Scoop
0
22
psw-placeholder
psw-placeholder

Courtesy of Benzinga.

Related CEMI
Morning Market Movers
Chembio Partners With Integrated BioTherapeutics, Inc. To Develop Point-of-Care Diagnostic Tests For Ebola And Febrile Illness

Shares of biotech Chembio Diagnostics Inc (NASDAQ: CEMI) got a dramatic boost in the arm Monday morning.

The Medford, New York-based firm announced a partnership with Integrated BioTherapeutics, Inc to develop and continue to maintain "exclusive rights to any POC (Point of Care) product developed through (their) agreement."

Chembio will combine its patented DPP(R) technology with IBT's proprietary Ebola reagents to develop POC diagnostic tests for Ebola and febrile illness.

At time of writing, shres were trading at a robust pace. Volume was up over 600 percent, when compared to Chembio's average three-month trading volume.

The stock was recently up 14.5 percent at $4.56, from previous close of $3.99 per share.

Posted-In: News Small Cap Events Intraday Update Movers

Subscribe
Notify of
0 Comments
Inline Feedbacks
View all comments

Stay Connected

157,328FansLike
396,312FollowersFollow
2,290SubscribersSubscribe

Latest Articles

Load more

Note: The material presented in this commentary is provided for informational purposes only and is based upon information that is considered to be reliable. However, neither PSW Investments, LLC d/b/a PhilStockWorld (PSW) nor its affiliates warrant its completeness, accuracy or adequacy and it should not be relied upon as such. Neither PSW nor its affiliates are responsible for any errors or omissions or for results obtained from the use of this information. Past performance, including the tracking of virtual trades and portfolios for educational purposes, is not necessarily indicative of future results. Neither Phil, Optrader, or anyone related to PSW is a registered financial adviser and they may hold positions in the stocks mentioned, which may change at any time without notice. Do not buy or sell based on anything that is written here, the risk of loss in trading is great.

This material is not intended as an offer or solicitation for the purchase or sale of any security or other financial instrument. Securities or other financial instruments mentioned in this material are not suitable for all investors. Any opinions expressed herein are given in good faith, are subject to change without notice, and are only intended at the moment of their issue as conditions quickly change. The information contained herein does not constitute advice on the tax consequences of making any particular investment decision. This material does not take into account your particular investment objectives, financial situations or needs and is not intended as a recommendation to you of any particular securities, financial instruments or strategies. Before investing, you should consider whether it is suitable for your particular circumstances and, as necessary, seek professional advice.

Contact us: support@philstockworld.com

© Copyright - PSW, LLC.

2024
0
Would love your thoughts, please comment.x
()
x